Avantor, Inc. (NYSE: AVTR) has announced an expanded partnership with the National Institute for Bioprocessing Research and ...

Recent advancements in monoclonal antibody engineering are reshaping disease treatment, focusing on safety, effectiveness, and addressing current medical needs.

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO ...

Zoetis enjoys enviable financial flexibility, even as leverage ticked up in 2015 to finance the purchase of Pharmaq and Abbott's animal health business. With long-term debt at roughly $6.6 billion at ...

The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...

R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins ...

The first in a series of Dotmatics Luma Multimodal R&D Solutions. Geneious has been seamlessly composed into Luma showcasing cross-therapeutic capabilities within a unified platfo ...

Scientists from the University of Sharjah think monoclonal antibodies hold the potential to be a far better treatment for ...

In 2022, the global monoclonal antibodies market size was valued at USD 186 billion in 2021. The market is projected to ...

A study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been ...

Identifying reliable operational parameters as early as possible in the development process can significantly streamline ...